Related Experiment Video
Updated: Aug 16, 2026
11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
A universal cell-based method for high-throughput analysis of viroporin function and inhibition
Viktoria M S Kjær1, Felix Faas1, Bo H Bentzen2
1Molecular and Translational Pharmacology, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.
Pharmacological Research
|August 14, 2026
Summary
A new fluorescence-based assay, VipoFluX, enables high-throughput screening for viroporin inhibitors. This method accelerates the discovery of antiviral drugs targeting viral pores essential for infection.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Viroporins are viral transmembrane proteins crucial for the viral life cycle.
- Targeting viroporins offers a promising strategy for antiviral drug development.
- Current methods for assessing viroporin activity lack high-throughput capabilities.
Purpose of the Study:
- To develop a novel, high-throughput, cell-based assay for viroporin activity and inhibition.
- To establish a versatile platform for discovering and characterizing viroporin inhibitors.
- To accelerate the identification of new antiviral drug candidates.
Main Methods:
- Development of VipoFluX, a fluorescence-driven, cell-based assay.
- Validation of VipoFluX using established assays and diverse viroporins.
- Screening of inhibitors against four key viroporin targets (M2, E, 2B, Vpu).
- Hit validation using two-electrode voltage clamp electrophysiology.
Main Results:
- VipoFluX demonstrated robustness and applicability across different viroporins.
- The assay successfully screened for inhibitors against influenza A virus M2, SARS-CoV-2 E, coxsackievirus B3 2B, and HIV-1 Vpu.
- Identified potential inhibitors were validated through electrophysiological methods.
Conclusions:
- VipoFluX is a scalable and versatile tool for viroporin research.
- This platform significantly advances high-throughput screening for antiviral drug discovery.
- The method facilitates the identification of novel inhibitors targeting essential viral proteins.
